MedPath

Influence of Osmotic Stimulation of Vasopressin on Autonomic Function

Not Applicable
Withdrawn
Conditions
Water Stress
Body Water Dehydration
Interventions
Other: Hypertonic Saline
Other: Normal Saline
Registration Number
NCT04233606
Lead Sponsor
University of North Carolina, Greensboro
Brief Summary

The regulation of total body water that defines human hydration status is a complex and dynamic process. Current methods of assessing hydration status (e.g. hematologic and urinary analyses) lack the ability to track changes in hydration status in real-time due to whole-body homeostatic physiologic processes required to maintain central pressure and cardiovascular function. This project will address this problem by assessing the relationship between autonomic function (measured using heart rate variability), a brain-derived process that regulates cardiovascular function, and changes in the hydration-mediated hormone vasopressin.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Males and Females between the ages of 18 - 35
Exclusion Criteria
    1. evidence of clinically relevant diseases that may alter body water regulation (e.g., diabetes, kidney disease, metabolic disorders, cardiovascular disease, and other potential fluid balance covariates such as habitual use of non-steroidal anti-inflammatory drugs or serotonin reuptake inhibitors,

    2. previous surgery on the digestive tract that may impair the body's ability to normally regulate body water,

    3. regular drug treatment within the previous 15 days,

    4. actively attempting to gain or lose body weight,

    5. For female participants, testing will take place during the early follicular phase of their menstrual cycle (days 1-8) to maintain consistency in the hydration status measures as total body water fluctuates over the course of the menstrual cycle. Females who are currently using contraceptives (e.g., IUD) that limit the number of menstrual cycles occurring in a given year will be excluded from this study to ensure accuracy in the testing periods for this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Hypertonic SalineHypertonic SalineParticipants will be infused with hypertonic (3% NaCL) saline for a 120 minute period.
ControlNormal SalineParticipants will be infused with normal (0.9% NaCL) saline for a 120 minute period.
Primary Outcome Measures
NameTimeMethod
Change in autonomic function0, 15, 30, 45, 60, 75, 90, 105, 120 minutes of saline infusion period

Changes in parasympathetic and sympathetic tone as measured by heart rate variability

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of North Carolina at Greensboro

🇺🇸

Greensboro, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath